Cannabis in Rheumatology Care: A Look at the Latest Research & What Rheumatologists Are Telling Their Patients

Carina Stanton is a freelance science journalist based in Denver.

References

1. Ingold J. A Colorado marijuana guide: 64 answers to commonly asked questions. The Denver Post. 2013 Dec 31.
2. Johnson, K. Sales of recreational marijuana begin in Washington state. The New York Times. 2014 Jul 8.
3. Hauser W, Fitzcharles MA. The perils of overestimating the efficacy of cannabis-based medicines for chronic pain management. Pain Physician. 2018 Jan;21(1):E79–E80.
4. Aviram J, Samuelly-Leichtag G. In response: Aviram J et al the perils of overestimating the efficacy of cannabis-based medicines for chronic pain management. Pain Physician. 2018 Jan;21(1):E81–E83.
5. Fitzcharles MA, Clauw DJ, Ste-Marie PA, et al. The dilemma of medical marijuana use by rheumatology patients. Arthritis Care Res (Hoboken). 2014 Jun;66(6):797–801.
6. Ste-Marie PA, Shir Y, Rampakakis E, et al. Survey of herbal cannabis (marijuana) use in rheumatology clinic attenders with a rheumatologist confirmed diagnosis. Pain. 2016 Dec;157(12):2792–2797.
7. Barrie N, Manolios N. The endocannabinoid system in pain and inflammation: Its relevance to rheumatic disease. Eur J Rheumatol. 2017 Sep;4(3):210-218.
8. Krcevski-Skvarc N, Wells C, Häuser W. Availability and approval of cannabis-based medicines for chronic pain management and palliative/supportive care in Europe: A survey of the status in the chapters of the European Pain Federation. Eur J Pain. 2018 Mar;22(3):440–454.